Companies / Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

NYSE: BIOCIK 12208HERCULES, CAbio-rad.com ↗

Financials · FY2025

Revenue$2.58B
Net income$759.90M
Total debt$1.20B
Cash$517.00M
Diluted EPS$27.85
Shares outstanding26.7M

Ownership

26.7M shares outstanding · as of Jul 30, 2026
0.03%Insiders
Ownership
81.1%Class A
Share classes
Class A81.07%
Class B18.93%
Insiders0.03%7,020
Institutions73.89%19,756,812
Public float26.08%6,974,343

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Lakkaraju Roop KalyanEVP, Chief Financial Officer
<0.01%2,564
Hinckley Greg KDirector
<0.01%1,215
Enloe Courtney CEVP, General Counsel & Sec
<0.01%750
Edwards Jeffrey LDirector
<0.01%715
Pei Melinda LitherlandDirector
<0.01%715
Pinkston Arnold aDirector
<0.01%715
Engelhardt Eva AnetteEVP, President, CDG
<0.01%346

Institutional holders 413

View all →
HolderValue% of shares
First Eagle Investment Management, LLC$725.52M9.73%
Vanguard Group Inc$537.58M6.64%
BlackRock, Inc.$498.82M6.35%
Dimensional Fund Advisors LP$326.34M4.03%
Ariel Investments, LLC$231.69M2.86%
State Street Corporation$167.88M2.14%
Veritas Asset Management LLP$164.63M2.03%
Earnest Partners LLC$164.11M2.20%
Capital Research Global Investors$149.82M1.85%
Bank of America Corp /De$134.97M1.67%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 11, 2026Engelhardt Eva Anette
Executive
SellBio-Rad A Common Stock$135.6K-550
-61.38%
346
<0.01% of shares
medium
Apr 24, 2026Lakkaraju Roop Kalyan
Executive
OtherBio-Rad A Common Stock$120.9K-420
-14.08%
2,564
<0.01% of shares
low
Apr 24, 2026Enloe Courtney C
Executive
OtherBio-Rad A Common Stock$22.2K-77
-9.31%
750
<0.01% of shares
low
Apr 24, 2026Enloe Courtney C
Executive
ExerciseBio-Rad A Common Stock$0+186
+29.03%
827
<0.01% of shares
low
Apr 24, 2026Lakkaraju Roop Kalyan
Executive
ExerciseBio-Rad A Common Stock$0+1K
+56.56%
2,984
0.01% of shares
low
Apr 21, 2026Pei Melinda Litherland
Director
ExerciseBio-Rad A Common Stock$0+407
+132.14%
715
<0.01% of shares
low
Apr 21, 2026Pinkston Arnold a
Director
ExerciseBio-Rad A Common Stock$0+407
+132.14%
715
<0.01% of shares
low
Apr 21, 2026Hinckley Greg K
Director
ExerciseBio-Rad A Common Stock$0+407
+50.37%
1,215
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BIO——090572207—